• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 17-06-2026: Press Release

    17-06-2026 | 08:37 am

    Glenmark Pharma USA launched Methylene Blue Injection USP, a generic equivalent to ProvayBlue® with ~$19.0 million (₹157.7 Cr) annual market sales. This expands their US institutional portfolio and strengthens market access.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited